EZH2 and infection: Upon intratumor injection with cisplatin, the size of xenograft tumors in co-infection group with p-EZH2 and si-SLC34A2 abolished the reduction in xenograft tumors resulting from si-SLC34A2 infection alone (Figure 7A).